Page 9 - Stroke Program News Today

A newer-generation clot-busting drug called tenecteplase outperforms the traditional treatment for ischemic strokes in several key areas, including better health outcomes and lower costs, according to a new study published today in the American Stroke Association's journal Stroke.

Dr. Nicholas Larochelle, M.D., Medical Director of Emergency Medicine, the Transfer Center, and the Stroke Program for the Concord Hospital health system discusses stroke symptoms, treatment, and prevention. What are the symptomsof a stroke?Stroke is...

BioPharma

~30% relative risk reduction seen in symptomatic ischemic strokes in three milvexian arms compared to placebo; dose response not observed for primary study objective No fatal bleeding and no increase

28.08.2022 - Bristol Myers Squibb (NYSE:BMY) in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), today announced results from the Phase 2 AXIOMATIC-SSP dose-ranging study of the ...

~30% relative risk reduction seen in symptomatic ischemic strokes in three milvexian arms compared to placebo; dose response not observed for primary

The Northwest Texas Healthcare System recently received national recognition for its stroke program from The American Heart Association.

ABC57 News in South Bend, Ind. covers all of Michiana including St. Joseph, Elkhart, Kosciusko, LaPorte and Marshall counties in Indiana and Berrien, Cass, Van Buren and St. Joseph counties in Mich.

A medical milestone in 2021 was the first TransCarotid Artery Revascularization (TCAR) at Memorial Regional Hospital. The innovative, minimally-invasive procedure prevents strokes in high-risk surgical patients with advanced coronary disease 

HOLLYWOOD, Fla. (PRWEB) June 29, 2022 -- The carotid artery in 81-year-old Reynold Zamora’s neck was nearly completely blocked with plaque, impeding the flow